Related Experiment Video
Updated: Jul 3, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Treatment strategies for amyloid A amyloidosis
T Pettersson1, Y T Konttinen, C P J Maury
1University of Helsinki and University Central Hospital, Department of Medicine, Helsinki, Finland.
Background:
Amyloid A (AA) amyloidosis is a serious complication of a wide range of chronic inflammatory, infectious and neoplastic diseases. A longstanding overproduction of the liver-synthesised cytokine-induced acute phase serum amyloid A (SAA) protein is a key event in the pathogenetic cascade leading to the deposition of AA amyloid in tissues and organs.
Objective:
The aim of the study was to critically review treatment strategies in AA amyloidosis.
Methods:
A systematic literature review was conducted based on PubMed (January 1980 - April 2008) and selected conference abstracts.
Results/Conclusions:
The current strategy for the treatment of AA amyloidosis is firmly based on the knowledge of the underlying pathogenetic mechanism and aims at reducing the amyloid precursor (SAA) load by intensive anti-inflammatory/immunosuppressive therapy and, in selected instances, anticytokine (TNF-alpha, IL-1beta or IL-6 blockade) therapy, or, when applicable, the eradication of an existing infectious focus (surgery, antimicrobial drugs). Emerging strategies focus on the dissolution of the amyloid deposits using small molecules that either interact with the glycosaminoglycans or the fibril component of the deposits, or deplete amyloid P component.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Pharmaceutical Poisoning: Treatment Strategies
Chronic Pancreatitis II: Collaborative Care
Assessment:
Nephrotic Syndrome III : Nursing Management

